title: [Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report].
abstract: A 51-year-old man received 2 courses of intravesical bacillus Calmette-Guerin (BCG) therapy for carcinoma in situ of the bladder. Two years after the therapy, he underwent left radical nephroureterectomy, cystectomy, urethrectomy and construction of an ileal conduit because of left renal pelvic cancer and severe atrophic bladder. The histopathological diagnosis was carcinoma in situ of the left pelvis and ureter, and epithelioid cell granuloma of left kidney, prostate and bladder. After the operation, he developed extensive surgical site infection (SSI) by BCG, the diagnosis of which was delayed. He recovered from the SSI soon after anti-tuberculosis chemotherapy was begun. We discuss the requirements for more prompt diagnosis of SSI by BCG by analysis of this case.
authors.affiliation: Department of Urology, Sapporo Medical University.
authors.forename: Takashi
authors.initials: T
authors.lastname: Muranaka
authors.forename: Yasuharu
authors.initials: Y
authors.lastname: Kunishima
authors.forename: Masanori
authors.initials: M
authors.lastname: Shigyo
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Kato
authors.forename: Naoya
authors.initials: N
authors.lastname: Masumori
authors.forename: Naoki
authors.initials: N
authors.lastname: Ito
authors.forename: Taiji
authors.initials: T
authors.lastname: Tsukamoto
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Takagi
authors.forename: Masaaki
authors.initials: M
authors.lastname: Seki
authors.forename: Ichiro
authors.initials: I
authors.lastname: Toida
mesh_terms: D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D015653:Cystectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D013530:Surgical Wound Infection / Q000209:etiology* / Q000382:microbiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
chemical_list: D001500:BCG Vaccine